Showing results (961-970 of 3,790) with videos related to
Sort By:
Pageof 379
Oncoimmunology|December 16, 2022
Generation and functional characterization of a multigene-modified NK101 cell line exerting diverse mechanisms of antitumor actionInjung Hwang, Hyun Tak Jin, Moon Cheol Kang, et al.Oncoimmunology|December 16, 2022
The role of NKT cells in gastrointestinal cancersJulian Burks, Purevdorj B Olkhanud, Jay A BerzofskyOncoimmunology|December 16, 2022
Bystander CD4+ T cells infiltrate human tumors and are phenotypically distinctShamin Li, Summer Zhuang, Antja Heit, et al.Oncoimmunology|December 16, 2022
Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patientsMartine Bloemendal, Kalijn F Bol, Steve Boudewijns, et al.Oncoimmunology|December 19, 2022
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse modelsClaudia Augusta Di Trani, Assunta Cirella, Leire Arrizabalaga, et al.Oncoimmunology|December 19, 2022
Suppression of prostate cancer and amelioration of the immunosuppressive tumor microenvironment through selective immunoproteasome inhibitionJulia Koerner, Dennis Horvath, Franziska Oliveri, et al.Oncoimmunology|May 13, 2015
Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancerMcA Wouters, E M Dijkgraaf, M L Kuijjer, et al.Oncoimmunology|May 13, 2015
Quantitative T cell repertoire analysis by deep cDNA sequencing of T cell receptor α and β chains using next-generation sequencing (NGS)Hua Fang, Rui Yamaguchi, Xiao Liu, et al.Oncoimmunology|May 8, 2015
Indoleamine 2,3-dioxygenase vaccinationMads Hald Andersen, Inge Marie SvaneOncoimmunology|May 8, 2015
Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancerSimone Punt, Gert Jan Fleuren, Eva Kritikou, et al.Pageof 379